Artificial intelligence (AI) is already bringing us capabilities we could only imagine a few years ago. Now, as we explore the next generation of GenAI and XAI capabilities, quantum computing is opening new possibilities in the identification of rare diseases, anomaly detection, image and sequence analyses, and countless other biomedical disciplines. Westat is focused on advancing bioinformatics specifically to taking advantage of the novel capabilities quantum computing brings into the field.
Westat’s Fatih Selekler and Nicole Barberis of IonQ Corporation will present “Innovating Regulatory Science with Quantum Computing” during the FDA’s 2024 Scientific Computing and Digital Transformation Symposium, November 4-6. Their discussion will be on how AI and quantum computing will transform regulatory science, followed by a panel discussion with the FDA scientific computing leadership.
